Eurofins Scientific (EUFI.PA), a global leader in bio-analytical testing, and one of the world leaders in genomic services, announces the acquisition of Megalab SA (“Megalab”), one of the top five clinical diagnostic laboratory groups in Spain, for approximately EUR 40m.



Téléchargez gratuitement le guide
Dopez vos plus-values

Headquartered in Madrid, where the central laboratory is based, Megalab operates 83 sites, of which 35 are located in private hospitals. It has the biggest geographical coverage in Spain with direct access to patients in 35 out of 50 provinces. With its strong reputation within the domestic healthcare industry for high-quality clinical testing services and its extensive geographic footprint, Megalab has entered into reimbursement agreements with the main private insurers offering their patients a broad range of diagnostic testing services including immunology, molecular diagnostics and cytogenetics. The company employs about 550 staff across its sites, and expects to generate revenues in excess of EUR 45m in 2016.

Megalab’s rapid growth in recent years validates its strategy of building market leadership both organically and through acquisitions, region-by-region. Given the ongoing consolidation in the clinical diagnostic testing market in Spain, Megalab is well-positioned to leverage and further strengthen its footprint in the country.

The acquisition of Megalab provides Eurofins entry into the clinical diagnostic testing market in Spain, and reinforces its footprint to serve healthcare professionals in Europe. In return, Eurofins’ vast analytical portfolio and technical resources, as well as the Group’s world class laboratory and systems infrastructure, should support the further development of Megalab’s portfolio of diagnostic tests and services, as well as the expansion of its footprint and client reach.

Comment from Dr. Gilles Martin, Eurofins CEO: “The acquisition of Megalab expands Eurofins’ clinical diagnostic footprint in Europe, and reinforces the platform on which to deploy the Group’s technical know-how and proprietary technologies, including our competencies in specialty diagnostic testing. We are committed to supporting Megalab in further developing its service offering and its geographic footprint to better serve its growing network of patients and clinicians in Spain.”


Téléchargez gratuitement le guide
Dopez vos plus-values

Recommander à vos amis
  • gplus
  • pinterest